AZ BIOTECH CONSULTING: what changed
AZ BIOTECH CONSULTING
Largest movements
- Cash -€7,049
down €7,049 (-44.9%), from €15,688 to €8,638
mainly Contributions, distributions and other (-€25,000) and Current investments (-€4,500)
- Receivables within one year -€6,315
down €6,315 (-21.8%), from €28,913 to €22,598
of which Other amounts receivable: -€17,965
- Current investments +€4,500
up €4,500 (+9.7%), from €46,499 to €50,999
- Tangible fixed assets -€2,079
down €2,079 (-11.0%), from €18,858 to €16,779
of which Other tangible fixed assets: -€1,902
- Reserves -€7,500
down €7,500 (-9.4%), from €79,845 to €72,345
- Tax, wage and social debts -€3,352
down €3,352 (-22.9%), from €14,668 to €11,316
- Gross operating margin -€12,095
down €12,095 (-28.0%), from €43,266 to €31,171
- Taxes -€4,065
down €4,065 (-31.0%), from €13,133 to €9,068
- Financial income -€1,633
down €1,633 (-77.3%), from €2,114 to €481
- Write-downs -€1,523
no longer reported in 2025 (was €1,523)
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €123,532 | €112,231 | -€11,301 | -9.1% |
| Fixed assets | 21/28 | €18,858 | €16,779 | -€2,079 | -11.0% |
| Tangible fixed assets | 22/27 | €18,858 | €16,779 | -€2,079 | -11.0% |
| Furniture and vehicles | 24 | €2,440 | €2,263 | -€177 | -7.3% |
| Other tangible fixed assets | 26 | €16,418 | €14,517 | -€1,902 | -11.6% |
| Current assets | 29/58 | €104,674 | €95,452 | -€9,222 | -8.8% |
| Amounts receivable after more than one year | 29 | €12,500 | €12,500 | = | 0.0% |
| Other amounts receivable | 291 | €12,500 | €12,500 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €28,913 | €22,598 | -€6,315 | -21.8% |
| Trade receivables | 40 | €10,948 | €22,598 | +€11,650 | +106% |
| Other amounts receivable | 41 | €17,965 | - | -€17,965 | |
| Current investments | 50/53 | €46,499 | €50,999 | +€4,500 | +9.7% |
| Cash at bank and in hand | 54/58 | €15,688 | €8,638 | -€7,049 | -44.9% |
| Deferred charges and accrued income | 490/1 | €1,075 | €717 | -€358 | -33.3% |
| Total equity and liabilities | 10/49 | €123,532 | €112,231 | -€11,301 | -9.1% |
| Equity | 10/15 | €80,212 | €72,916 | -€7,297 | -9.1% |
| Reserves | 13 | €79,845 | €72,345 | -€7,500 | -9.4% |
| Distributable reserves | 133 | €79,845 | €72,345 | -€7,500 | -9.4% |
| Profit (loss) carried forward | 14 | €367 | €571 | +€203 | +55.4% |
| Amounts payable | 17/49 | €43,320 | €39,316 | -€4,005 | -9.2% |
| Amounts payable within one year | 42/48 | €43,320 | €39,316 | -€4,005 | -9.2% |
| Trade debts | 44 | €3,652 | €3,000 | -€653 | -17.9% |
| Suppliers | 440/4 | €3,652 | €3,000 | -€653 | -17.9% |
| Taxes, remuneration and social security | 45 | €14,668 | €11,316 | -€3,352 | -22.9% |
| Taxes | 450/3 | €14,668 | €11,316 | -€3,352 | -22.9% |
| Other amounts payable | 47/48 | €25,000 | €25,000 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,936 | €3,200 | +€264 | +9.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €1,523 | - | -€1,523 | |
| Other operating charges | 640/8 | €397 | €758 | +€361 | +90.8% |
| Gross operating margin | 9900 | €43,266 | €31,171 | -€12,095 | -28.0% |
| Operating profit (loss) | 9901 | €38,410 | €27,213 | -€11,197 | -29.2% |
| Financial income | 75/76B | €2,114 | €481 | -€1,633 | -77.3% |
| Recurring financial income | 75 | €2,114 | €481 | -€1,633 | -77.3% |
| Financial charges | 65/66B | €1,024 | €922 | -€102 | -9.9% |
| Recurring financial charges | 65 | €1,024 | €922 | -€102 | -9.9% |
| Profit (loss) for the period before taxes | 9903 | €39,500 | €26,772 | -€12,729 | -32.2% |
| Income taxes | 67/77 | €13,133 | €9,068 | -€4,065 | -31.0% |
| Profit (loss) for the period | 9904 | €26,367 | €17,703 | -€8,664 | -32.9% |
| Profit (loss) for the period to be appropriated | 9905 | €26,367 | €17,703 | -€8,664 | -32.9% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.